CeriBell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of pat…
Healthcare
US, Sunnyvale [HQ]
Cash Flow Statements
2 Records · Starting from 2022In Million USD. Margins, Growth Rates In %
| Metric | 2022 | 2023 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Cash Flow (OCF) | -32.00 | -29.00 | |
| Operating Cash (Net) | -32.00 | -29.00 | |
| Accounts Receivable | -3.00 | -3.00 | |
| Accounts Payable | - - | - - | |
|
Working Capital
|
- - | - - | |
| Change | -3.00 | -3.00 | |
| Other WC | 1.00 | 1.00 | |
| Investing Activities | |||
| Used Cash (Net) | -1.00 | -1.00 | |
| Capital Expenditure | - - | - - | |
| Purchases of Investments | - - | - - | |
| Sale/Maturity of Investment | - - | - - | |
| Property, Plant, Equipment (P&PE) | - - | - - | |
| Acquisitions (Net) | - - | - - | |
| Other Investing Activities | - - | - - | |
| Financing Activities | |||
| Used Cash (Net) | -49.00 | -2.00 | |
| Debt Repayment | - - | -3.00 | |
| Dividends Paid | - - | - - | |
|
Common Stock
|
- - | - - | |
| Issued | - - | - - | |
| Repurchased | - - | - - | |
| Other Financing Activities | 49.00 | - - | |
| Cash Balances | |||
| Begin of Period | 51.00 | 68.00 | |
| End of Period | 68.00 | 34.00 | |
| Change | 16.00 | -33.00 | |
| Non-Cash Balances | |||
| Depreciation and Amortization | - - | - - | |
| Stock Based Compensation | 7.00 | 2.00 | |
| Other | - - | - - | |
| Highlighted metrics | |||
| Free Cash Flow (FCF) | -32.00 | -30.00 | |
| Cash Conversion Cycle (CCC) | 375.00 | 329.00 | |
| Invested Capital | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||
| Forex Effect on Cash | - - | - - |